《校長報告書》 1982–85

— . " T he oral absorption of anticholinesterase (Anti-ChE) agent s in patients with myasthenia gravis (MG).” In Papers of The Drug Aspects of Gastrointestinal Motility, Secretion and Absorption, IUPHAR Satellite Symposium, p. A2. U.K.: Society for Drug Research, 1984. — •“The simultaneous determination of carbamazepine and it s epoxide metabolite in plasma and urine by high performance liquid chromatography." Journal of Chromatography (Amsterdam), 1985.3. — ； (Pillings, M.; and Tse, J.) “A modified gas-liquid chromatographic assay to monitor plasma mexiletine in a tinnitus study,”Methods and Findings in Experimental and Clinical Pharmacology (Spain), 4 (1982), pp. 243-247. - ； ( O r m e , M.L'E.; Sibeon, R.G.; and Tse , J.) “The influence of urinary pH on the disposition of indomethacin in healthy volunteers." Journal of Clinical and Hospital Pharmacy (U.K.), 7 (1982), pp. 155-160. — ； (Calvey, T.N.; Murray, G.R.; and Mushtaq, T.) "Plasma protein binding of phenoperidine." Journal of Pharmacy and Pharmacology (U.K.), 34-Supplement (1982), p. 95. — ； (Calvey, T.N.; and Williams, N.E.) “Plasma concentration s of pyridostigmine during the antagonism of neuromuscular block.” British Journal of Anaesthesia, 55 (1983 )， pp. 27-31. — ； (Calvey, T.N.; Milne, L.A.; Murray, G.R.; and Williams, N.E.) “Effect of antacids on the plasma concentration of phenoperidine." British Journal of Anaesthesia, 55 (1983), pp. 535-539. — ； (Calvey, T.N.; Murray, G.R.; and Williams, N.E.) "Variability of phenoperidine metabolism in man." British Journal of Clinical Pharmacology, 15 (1983 )， p. 154. — ； (Jennings, F.; Orme, M.L'E.; and Tse, J.) “Plasma concentration of pethidine in Caucasian and Chinese subjects." British Journal of Clinical Pharmacology , 15 (1983), pp. 155-156. — ； (Jennings, F.; Orme, M.L'E.; and Tse, J.) “Pethidine metabolism in Caucasian and Chinese subjects." British Journal of Clinical Pharmacology, 15 (1983), pp. 606-607. — ； (Calvey, T.N.; Milne, L.A.; Murray, G.R.; and Williams, N.E.) “Effect of urine pH on the elimination of phenoperidine .” British Journal of Clinical Pharmacology, 16 (1983 )， pp. 101-103. — ； (Deeks,P.A.; Pillings, M.; and Tse, J.) "The dissolution and oral bioavailability of mexiletine capsules modified for clinical trial: A preliminary report." Methods and Findings in Experimental and Clinical Pharmacology (Spain), 5 (1983), pp. 471-478. — ； (Jennings, F.; Orme, M.L'E. ; and Tse, J.) "Plasma protein binding of pethidine in renal patients." Journal of Pharmacy and Pharmacology (U.K.), 35-Supplement (1983 )， p. 94. — ； (Jennings, F.; Orme, M.L'E.; and Tse, J.) “The influence of renal dysfunction on the disposition of pethidine in man.” British Journal of Clinical Pharmacology, 17 (1984 )， p. 198. 一 ； (Calvey, T.N.; Isherwood, C.N.; Murray, G.R.; and Williams, N.E.) “Elimination of phenoperidine in liver disease.” British Journal of Anaesthesia, 56 (1984 )， pp. 843-847. — ； (Calvey, T.N.; Murray, G.R.; and Williams, N.E.) "Quantitative capillary column gas chromatographic method for the determination of glycopyrronium in human plasma." Journal of Chromatography (Amsterdam), 308 (1984), pp. 143-151. — ； (Jennings, F.; Orme, M.L'E.; and Tse, J.) "Variability of pethidine metabolism among Caucasian, Chinese and Indian subjects.” In Papers of The Sixth International Symposium on Microsomes and Drug Oxidations (P.4/23), p. 102. U.K.: Taylor and Francis, 1984. — ； (Elliott, P.N.C.; and Ford, J.L.) “The effect of incorporation of indomethacin with polyethylene glycol 6000 in a solid dispersion on its in vivo properties in the rat：" Agents and Actions, 15:3/4 (1984), pp. 367-370. 一 ； (Jennings, F.; Orme, M.L'E.; and Tse, J.) "Influence of urinary pH on pethidine kinetics in healthy volunteer subjects." Methods and Findings in Experimental and Clinical Pharmacology (Spain), 1985.5. - ： → 067 ， 068 ， 121,122, 123,290. Gardiner ， John — ︰ →067. Pak ， Raphael C. K. 白正君 — and (Ecobichon, D.J.) “Disposition of maternally-administered methadone and its effects on hepatic drug-metabolizing functions in perinatal guinea pigs." Biochemical Pharmacology (U.K.), 31:18 (1982), pp. 2941-2948. — ； (Bellward, Gail D.; Finlayson, Malcolm; Gontovnick, Larry; Sunahara ， Geoffrey; and Warren, Betty L.) “Differential effects of diabetes on microsomal metabolism of various substrates: Comparison of streptozotocin and spontaneously diabetic Wistar Rats." Biochemical Pharmacology (U.K.), 32:2 (1983 )， pp. 327-335. — ： → 067 ， 068, 290, 306, 307, 308, 309, 310, 311, 312. Wong, Chak-lam 黃澤霖 — • "The effects of morphine and nalbuphine on intestinal transit in mice." Methods and Findings in Experimental and Clinical Pharmacology (Spain), 6:11 (1984), pp. 685-689. — • “The possible involvement of adrenoceptors in the intestinal effect of morphine in mice .” Clinical and Experimental Pharmacology and Physiology (Australia), 11 (1984), pp. 605-610. — .“Characterization of nalbuphine using the phenomenon of increased naloxone potency in mice .” Neuroscience Letters 16-Supplement (1984.6), p. S37. 86